Gennex Laboratories Balance Sheet Health
Financial Health criteria checks 5/6
Gennex Laboratories has a total shareholder equity of ₹1.8B and total debt of ₹189.4M, which brings its debt-to-equity ratio to 10.7%. Its total assets and total liabilities are ₹2.3B and ₹535.2M respectively. Gennex Laboratories's EBIT is ₹140.2M making its interest coverage ratio 4.6. It has cash and short-term investments of ₹609.8M.
Key information
10.7%
Debt to equity ratio
₹189.37m
Debt
| Interest coverage ratio | 4.6x |
| Cash | ₹609.75m |
| Equity | ₹1.76b |
| Total liabilities | ₹535.21m |
| Total assets | ₹2.30b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 531739's short term assets (₹1.6B) exceed its short term liabilities (₹403.0M).
Long Term Liabilities: 531739's short term assets (₹1.6B) exceed its long term liabilities (₹132.2M).
Debt to Equity History and Analysis
Debt Level: 531739 has more cash than its total debt.
Reducing Debt: 531739's debt to equity ratio has reduced from 13.4% to 10.7% over the past 5 years.
Debt Coverage: 531739's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: 531739's interest payments on its debt are well covered by EBIT (4.6x coverage).